These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17146603)

  • 1. Positive troponin-T in noncompaction is associated with neuromuscular disorders and poor outcome.
    Finsterer J; Stöllberger C; Krugluger W
    Clin Res Cardiol; 2007 Feb; 96(2):109-13. PubMed ID: 17146603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of CK-elevation in noncompaction with regard to cardiac and neuromuscular disease.
    Finsterer J; Stöllberger C; Krugluger W
    Int J Cardiol; 2008 Nov; 130(2):174-9. PubMed ID: 18055044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular comorbidity, heart failure, and atrial fibrillation as prognostic factors in left ventricular hypertrabeculation/noncompaction.
    Stöllberger C; Blazek G; Gessner M; Bichler K; Wegner C; Finsterer J
    Herz; 2015 Sep; 40(6):906-11. PubMed ID: 25939437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular implications in left ventricular hypertrabeculation/noncompaction.
    Finsterer J; Stöllberger C; Blazek G
    Int J Cardiol; 2006 Jun; 110(3):288-300. PubMed ID: 16364474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiologic and neuromuscular co-morbidity influences mortality of patients with left ventricular hypertrabeculation/noncompaction: comparison with the Austrian general population.
    Stöllberger C; Winkler-Dworak M; Blazek G; Finsterer J
    Acta Cardiol; 2007 Feb; 62(1):1-5. PubMed ID: 17375885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular hypertrabeculation/noncompaction, cardiac phenotype, and neuromuscular disorders.
    Stöllberger C; Wegner C; Finsterer J
    Herz; 2019 Nov; 44(7):659-665. PubMed ID: 29626229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of electrocardiographic abnormalities with cardiac findings and neuromuscular disorders in left ventricular hypertrabeculation/non-compaction.
    Stöllberger C; Winkler-Dworak M; Blazek G; Finsterer J
    Cardiology; 2007; 107(4):374-9. PubMed ID: 17284898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation in left ventricular noncompaction with and without neuromuscular disorders is associated with a poor prognosis.
    Stöllberger C; Blazek G; Winkler-Dworak M; Finsterer J
    Int J Cardiol; 2009 Mar; 133(1):41-5. PubMed ID: 18255171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular hypertrabeculation/noncompaction and neuromuscular disorders in idiopathic dilated cardiomyopathy.
    Stöllberger C; Leitner S; Kopsa W; Finsterer J
    Acta Cardiol; 2004 Aug; 59(4):425-30. PubMed ID: 15368805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncompaction and neuromuscular disease with positive troponin-T in a nonagenerian.
    Finsterer J; Stöllberger C
    Clin Cardiol; 2007 Oct; 30(10):527-8. PubMed ID: 17929284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological comorbidity affects prognosis in left ventricular hypertrabeculation/noncompaction.
    Stöllberger C; Blazek G; Wegner C; Finsterer J
    Heart Lung; 2012; 41(6):594-8. PubMed ID: 22515930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of left ventricular hypertrabeculation/noncompaction is dependent on cardiac and neuromuscular comorbidity.
    Stöllberger C; Winkler-Dworak M; Blazek G; Finsterer J
    Int J Cardiol; 2007 Oct; 121(2):189-93. PubMed ID: 17188376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure, atrial fibrillation and neuromuscular disorders influence mortality in left ventricular hypertrabeculation/noncompaction.
    Stöllberger C; Blazek G; Wegner C; Finsterer J
    Cardiology; 2011; 119(3):176-82. PubMed ID: 21968288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of electrocardiographic abnormalities in association with neuromuscular disorders and survival in left ventricular hypertrabeculation/noncompaction.
    Stöllberger C; Gerger D; Jirak P; Wegner C; Finsterer J
    Ann Noninvasive Electrocardiol; 2014 Nov; 19(6):567-73. PubMed ID: 24934299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiologic and neurologic findings in left ventricular hypertrabeculation/non-compaction related to wall thickness, size and systolic function.
    Stöllberger C; Finsterer J
    Eur J Heart Fail; 2005 Jan; 7(1):95-7. PubMed ID: 15642538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular disorders in left ventricular hypertrabeculation/noncompaction.
    Finsterer J; Stöllberger C; Fazio G
    Curr Pharm Des; 2010; 16(26):2895-904. PubMed ID: 20632953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac and noncardiac, particularly neuromuscular, disease with troponin-T positivity.
    Finsterer J; Stöllberger C; Krugluger W
    Neth J Med; 2007 Sep; 65(8):289-95. PubMed ID: 17890788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between takotsubo syndrome, left ventricular hypertrabeculation/noncompaction, neurologic and neuromuscular disorders.
    Stöllberger C; Finsterer J
    Rev Cardiovasc Med; 2021 Dec; 22(4):1413-1420. PubMed ID: 34957781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Neuromuscular Co-morbidity, Left Bundle Branch Block, and Atrial Fibrillation to Predict the Long-Term Prognosis of Left Ventricular Hypertrabeculation/Noncompaction.
    Stöllberger C; Hasun M; Winkler-Dworak M; Finsterer J
    Am J Cardiol; 2020 Aug; 128():168-173. PubMed ID: 32650915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familal left ventricular hypertrabeculation (noncompaction) is myopathic.
    Finsterer J; Stöllberger C; Blazek G; Sehnal E
    Int J Cardiol; 2013 Apr; 164(3):312-7. PubMed ID: 21788087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.